PROCEPT BioRobotics Corporation Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2023-02-28: Form 10-K; Item Smaller reporting company; As filed Yes.
- 2022-11-04: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2022-11-04: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2022-08-05: Form 10-Q; Item Smaller reporting company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2023-02-28 | 10-K | Smaller reporting company | Yes |
| 2022-11-04 | 10-Q | Smaller reporting company | Yes |
| 2022-11-04 | 10-Q | Emerging growth company | Yes |
| 2022-08-05 | 10-Q | Smaller reporting company | Yes |
| 2022-08-05 | 10-Q | Emerging growth company | Yes |
| 2022-05-06 | 10-Q | Smaller reporting company | Yes |
| 2022-05-06 | 10-Q | Emerging growth company | Yes |
| 2022-03-22 | 10-K | Smaller reporting company | Yes |
| 2022-03-22 | 10-K | Emerging growth company | Yes |
| 2022-03-22 | 10-K | Well-known seasoned issuer | No |
| 2021-11-05 | 10-Q | Smaller reporting company | Yes |
| 2021-11-05 | 10-Q | Emerging growth company | Yes |
| 2021-11-05 | 10-Q | Current in its reporting | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |